1-(carboxymethylthio)tetradecane and Atherogenesis

1-(carboxymethylthio)tetradecane has been researched along with Atherogenesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aukrust, P; Berge, RK; Bjørndal, B; Bohov, P; Brattelid, T; Busnelli, M; Chiesa, G; Dellera, F; Ganzetti, GS; Halvorsen, B; Holm, S; Manzini, S; Nygård, OK; Parolini, C; Sirtori, CR; Vik, R	1

Other Studies

1 other study(ies) available for 1-(carboxymethylthio)tetradecane and Atherogenesis

Article	Year
An immunomodulating fatty acid analogue targeting mitochondria exerts anti-atherosclerotic effect beyond plasma cholesterol-lowering activity in apoe(-/-) mice. PloS one, 2013, Volume: 8, Issue:12 Topics: Animals; Apolipoproteins E; Atherosclerosis; Body Weight; Cholesterol; Diet, High-Fat; Dietary Supplements; Fatty Acids; Female; Gene Expression Regulation; Immunologic Factors; Inflammation; Liver; Mice; Mitochondria; Myocardium; Oxidative Stress; RNA, Messenger; Sulfides	2013

Article

Year

An immunomodulating fatty acid analogue targeting mitochondria exerts anti-atherosclerotic effect beyond plasma cholesterol-lowering activity in apoe(-/-) mice.

PloS one, 2013, Volume: 8, Issue:12

Topics: Animals; Apolipoproteins E; Atherosclerosis; Body Weight; Cholesterol; Diet, High-Fat; Dietary Supplements; Fatty Acids; Female; Gene Expression Regulation; Immunologic Factors; Inflammation; Liver; Mice; Mitochondria; Myocardium; Oxidative Stress; RNA, Messenger; Sulfides

2013